KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size

American Journal of Pathology

Volumn 160, Issue 5, 2002, Pages 1567-1572

  Corless, Christopher L ^a,b,c   McGreevey, Laura ^a,b,c   Haley, Andrea ^a,b,c   Town, Ajia ^a,b,c   Heinrich, Michael C ^a,b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER SIZE; EXON; FEMALE; GASTROINTESTINAL TUMOR; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUTATION RATE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOMATIC MUTATION; STROMA;

EID: 0036092268     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61103-0     Document Type: Article

References (26)

1. Gastrointestinal stromal tumors - Definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis
2. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
3. CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34
4. A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors
5. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors
6. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas
7. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors
8. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors
9. Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit
10. Gastrointestinal stromal tumor with a novel mutation of KIT proto-oncogene
11. Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours
12. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors
13. Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese
14. Chromosomal aberrations in malignant gastrointestinal stromal tumors: Correlation with c-KIT gene mutation
15. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: Biological and clinical implications
16. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
17. Evaluation of the safety and efficacy of an oral molecularly-targeted therapy, STI571, in patients with unresectable or metastatic gastrointestinal stromal tumors (GISTs) expressing c-kit (CD117)
18. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: A phase I study
19. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors
20. Analysis of KIT mutation and protein expression in fine needle aspirates of gastrointestinal stromal/smooth muscle tumors
21. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases
22. Mesenchymal tumors of muscularis mucosae of colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors - A clinicopathologic and immunohistochemical study of eighty-eight cases
23. Familial gastrointestinal stromal tumor with hyperpigmentation: Association with a germline mutation of the c-kit gene
24. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene
25. Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors
26. Cause of familial and multiple gastrointestinal autonomic nerve tumors with hyperplasia of interstitial cells of Cajal is germline mutation of the c-kit gene